Targeted reduction of KLF6-SV1 restores chemotherapy sensitivity in resistant lung adenocarcinoma
Authors:
- 31 December 2009
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 66 (3) , 292-297
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasisJournal of Clinical Investigation, 2008
- A Functional Role for KLF6-SV1 in Lung Adenocarcinoma Prognosis and Chemotherapy ResponseCancer Research, 2008
- ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancerCurrent Opinion in Pulmonary Medicine, 2007
- Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal DisseminationClinical Cancer Research, 2006
- A Germline DNA Polymorphism Enhances Alternative Splicing of the KLF6 Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer RiskCancer Research, 2005
- Frequent inactivation of the tumor suppressor Kruppel-like factor 6 ( KLF6 ) in hepatocellular carcinomaHepatology, 2004
- Krüppel-Like Factor 6 Is Frequently Down-Regulated and Induces Apoptosis in Non-Small Cell Lung Cancer CellsCancer Research, 2004
- Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancerCancer Genetics and Cytogenetics, 2004
- KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomasInternational Journal of Cancer, 2003
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002